1. Uhl K., FDA Voice [Internet]. Generic drug user fees reauthorization: a victory for public health. 2017.
https://blogs.fda.gov/fdavoice/index.php/tag/generic-drugs/
. Accessed 28 Nov 2017.
2. U.S. Food & Drug Administration. What We Do. 2017.
https://www.fda.gov/AboutFDA/WhatWeDo/default.htm
. Accessed 28 Nov 2017.
3. Oner ZG, Michel SLJ, Polli JE. Equivalence and regulatory approaches of nonbiological complex drug products across the United States, the European Union, and Turkey. Ann N Y Acad Sci. 2017;1407:26–38.
https://doi.org/10.1111/nyas.13505
.
4. U.S. Food & Drug Administration. Generic Drugs: Questions & Answers. 2017.
https://www.fda.gov/Drugs/ResourcesForYou/Consumers/QuestionsAnswers/ucm100100.htm#q1
. Accessed 28 Nov 2017.
5. U.S. Food & Drug Administration. Abbreviated New Drug Application (ANDA). 2017.
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/default.htm
. Accessed 28 Nov 2017.